ESAF Small Finance Bank IPO: How Its Valuation Compares With That Of Listed Peers
ESAF Small Finance Bank Ltd.'s public issue will open for subscription on Friday.
The three-day offer, priced in the range of Rs 57 to Rs 60 per share, will conclude on Nov. 7.
The initial public offering comprises fresh issuance of equity shares worth Rs 390.7 crore and an offer for sale of up to Rs 72 crore, aggregating to Rs 463 crore.
The Kerala-based lender proposes to utilise the proceeds of the fresh issue to augment its Tier-1 capital base. Raising of funds also helps them to ensure compliance with regulatory requirement on capital adequacy.
ESAF Financial Holdings Pvt. and Kadambelil Paul Thomas are the promoters of the bank. Currently, promoters collectively hold 31.2 crore equity shares, equivalent to 69.40% of the pre-offer issued, subscribed and paid-up equity share capital of the bank.
The bank has focused on unbanked and underbanked customer segments, especially in rural and semi-urban centres.
Between March 31, 2021, and the same period in 2023, the bank's assets under management grew from Rs 8,426 crore to Rs 16,331 crore, with a compound annual growth rate of 39%. Its net interest margin stood at 9.68% in the previous financial year, from 7.64% in fiscal 2022.
Its fully diluted earnings per share was Rs 6.71 in the financial year ended March 31, 2023, according to the company's red herring prospectus.
Valuation Snapshot
Based on the upper end of the share price band, the issue presents a market capitalisation of Rs 3,088 crore, with a price-to-equity ratio at 8.94 times, based on the EPS for the previous fiscal.
At a higher price band, the stock is valued at 1.46 times the price-to-book value, with current book value per share of Rs 40.92, LKP Securities in a note.
The brokerage said ESAF Small Finance Bank is worth subscribing, factoring the superlative return ratio—1.6% return on assets and 19.4% return on equity.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.